However, the indicators of dyslipidemia (i.e., increased serum concentrations of cholesterol and triglycerides), as well as increased serum uric acid concentration, increased urine NGAL concentration, and increased megalin daily excretion, appeared only in “decreased GFR” adolescents. Here, LCN2 is linked to metabolic syndrome.